
|Articles|November 15, 2003
FDA to allow inserts for keratoconus patients
Des Plaines, IL-Micro-thin prescription inserts (Intacs, Addition Technology Inc.) may be used to reduce or eliminate myopia and astigmatism in patients with keratoconus for whom restoration of functional vision is no longer possible with contact lenses or glasses, under a new designation by the FDA.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
Opuviz aflibercept biosimilar launches in Europe for retinal diseases
4
Study links alcohol consumption to earlier advanced presbyopia in men
5





















